☰ Accessibility

View on market: Volatility persists, eagerly searching for growth:

Asian markets opened on a mixed note on Monday, with Japan’s Nikkei and Topix trading higher, while South Korea’s Kospi and Australia’s ASX declined. Investors remained cautious ahead of a busy week of corporate earnings and economic data, particularly from major technology and AI companies. Uncertainty surrounding Nvidia added pressure on technology stocks, while investors also awaited key US inflation data for further direction on the economic outlook. US stock futures initially traded higher, supported by hopes of a continued recovery in technology shares. However, Nasdaq futures later turned negative following reports of an investigation involving Nvidia CEO Jensen Huang, raising concerns ahead of major AI earnings and economic announcements. Indian benchmark indices ended the special Muhurat trading session in the red, breaking their long winning streak as early gains faded towards the close. The Sensex and Nifty closed marginally lower. However, on Friday, domestic markets extended their rally for the seventh consecutive session, supported by strong buying in private banking and pharmaceutical stocks despite weakness in global markets.

Key Quarterly Results for Today:

GULFLLOYDS, HBLEAS, HBPOR, MANRAJH, MEDICO, NICCOPAR, OLECTRA, PARKHOSPS, RMDRIP, SVPGLOB, THRIVE, TIRUFIN, VENTURA, WHIRLPOOL.

Economic Calendar:

  • USD: ADP Employment Change Data and CPI Oct on 10th November 2026.
  • IND: CPI on 12th November 2026.
  • USD: API Crude Oil Stock Change and MBA 30 – Year Mortgage Rate on 11th November 2026.
  • IND: Bank Deposit & Loan Growth Rate and Foreign Reserves Data on 13th November 2026.

BROKERAGE:

MORGAN STANLEY ON HINDALCO INDUSTRIES:

Maintains OVERWEIGHT rating; Target Price at ₹1,140, Consolidated EBITDA of ₹128 billion beats Morgan Stanley’s estimate and consensus, Domestic EBITDA of ₹90 billion comes 13% above the house estimate, Copper EBITDA of ₹16.7 billion beats the house estimate by 60%, Copper performance benefits from strong demand, higher sulphuric acid prices and one-time gains, Consolidated PAT of ₹75 billion misses the house estimate of ₹81 billion, Net debt-to-EBITDA eases to 1.80x from 1.95x.

MORGAN STANLEY ON MPHASIS:

Maintains OVERWEIGHT rating, Raises Target Price to ₹2,900 from 2,730, Guidance upgrade provides greater visibility into H2 growth, Sees margins towards the lower end of the 14.75-15.75% band in FY27, Expects cash flow to normalise from H2FY27, with further improvement in FY28, Raises FY27E revenue growth forecast to around 10% in constant currency terms, Expects OCF to net income to fall short of the 80% guidance in FY27, Raises EPS estimates by 1-4% and scenario valuations by 4-11%, Sees room for further re-rating.

ELARA CAPITAL ON ADANI PORTS & SEZ:

Reiterates its Buy rating, raises Target Price to 2,432 from ₹2,107, The company plans to acquire, Netherlands-based Evos at an enterprise value of €2.56 billion, The all-cash, debt-funded deal is valued at 11.4x CY26E EV/EBITDA, Evos, Europe’s second-largest independent liquid storage operator, has an EBITDA margin of 56% versus 44.8% for Adani Ports’ international ports, The acquisition expands the company’s 5900 footprint to 28 ports and terminals across 10 countries, Elara expects the deal to support growth, with the Target Price raised on a valuation roll-forward to FY29E.

International Markets:

U.S & Europe:

Particulars     06th  Nov   Chg. Chg.(%)
Nasdaq 24,579.43 264.43 1.09
Dow 51,285.73 -237.33 -0.46
FTSE 10,673.94 -108.72 -1.01
CAC 8,139 -66.37 -0.81
DAX 25,820.36 -504.65 -1.92
Dow Fut.* 51,668.50 382.77 0.75
*As per 09th November

Asian markets:

Particulars 09th  Nov Chg. Chg.(%)
GIFT Nifty                  25,057 52 0.21
Nikkei 59,335 1,900.23 3.31
Straits Times** 5,179.17 -117.08 -2.26
Hang Seng 24,564.00 82.14 0.34
Taiwan Weighted 42,069.12 2,367.48 5.99
KOSPI 5,151.38 91.69 1.81
Shanghai 3,670.54 21.36 0.59
*As per 09th November

Stocks strong on Chart:

Index F&O Cash
AXISBANK CROMPTON IKIO
BHARTIARTL GLENMARK LINDEINDIA
HDFCLIFE HAVELLS SAILIFE
ICICIBANK KALYANKJIL TVSELECT
M&M TITAN WABAG
SBIN YESBANK WINDLAS

Commodities & Currency:

Particulars Current Price Chg. (%)
USD/INR 93.91 -0.60
Brent 97.864 -0.46
Gold 142,520 -0.02
Silver 185,011 -0.05

FIIs & DIIs:

Particulars       08th Nov        06th Nov
FIIs                  -0.25 13,749.82
DIIs -700.31 -5,968.70

FII & DII Data in Cr.

News Updates:

Cohance Lifesciences: US FDA classifies its Pashamylaram unit as VAI. US FDA issues Establishment Inspection Report for the unit.
Religare Enterprises: Arm Religare Finvest resumes its lending business.
Amber Enterprises: Arm IL JIN Electronics files DRHP with SEBI for IPO. Aims to raise ₹2,500 crore through the IPO.
Waaree Energies: Secured a domestic order from a leading power producer. Bags an EPC contract for the supply of 285 MWp solar power.
BHEL: Received an order worth ₹600–900 crore from Power Grid. Order involves construction of two synchronous condensers at the Barmer-II HVDC unit.
Tata Motors: Increases its stake in Iveco Group NV to 96.3%. Additional 1.83 crore shares tendered during the reopening of the offer.

Disclaimer:

InCred Markets Limited (“the Company”), Formerly known as Elite Wealth Limited (The company is Wholly Owned Subsidiary of InCred Capital Financial Services Limited) does/ does not do business with companies covered in its research reports. Investors should be aware that the Company may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.incredmarkets.com. Analysts employed by the Company are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Vindhyachal Prasad, InCred Markets Limited, vindhyachal@elitestock.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in the Company.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
1. All of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
2. No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report. For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.incredmarkets.com.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all InCred Markets Limited covered companies by visiting www.incredmarkets.com. or emailing research@elitestock.com with your request. The Company may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at www.incredmarkets.com.
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
InCred Markets Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of the Company. Analyst as officer or director: The Company’s policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Use of Artificial Intelligence Tools (AI)
• The Research Analyst may use Artificial Intelligence (AI) tools, to the extent applicable, for supporting research activities such as data analysis, processing of information, research assistance and preparation of research materials.
• AI tools are used only as supporting tools in the research process. All research recommendations and services remain subject to the Research Analyst’s review, verification and professional judgment. The Research Analyst remains responsible for the research services provided, including the accuracy and integrity of the information used, protection of client data, confidentiality and compliance with applicable laws and SEBI regulations.
• The extent and nature of AI usage may vary depending on the research activity. The Research Analyst shall make additional disclosures regarding AI usage whenever required.

Country Specific Disclosures
India – For private circulation only, not for sale. Legal

Entities Disclosures
InCred Markets Limited (Formerly known as Elite Wealth Limited) (IML henceforth), is a SEBI Registered Analyst having registration no. INH100002300, having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, Telephone: 0120-4477777, and Website: www.incredmarkets.com. There is no material conflict of interest with the subject company. The company and the Research Analyst have no actual or beneficial interest of one percent or more in the subject company.

The Company discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) IML or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
b) IML or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
c) IML or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
a) IML or its associates have not received any compensation from the subject company in the past twelve months;
b) IML or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
c) IML or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
d) IML or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
e) IML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3. In respect of Public Appearances
a) IML or its associates have not received any compensation from the subject company in the past twelve months;
b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by IML